observation
OtherObservation
NCT Number: NCT01216930
A clinically applicably strategy for molecular screening for Lynch Syndrome has been implemented in the Region of Southern Denmark.
Based on sequential analysis with immunohistochemistry and methylation analysis, patients with possible hereditary colorectal cancer are identified. These patients are offered genetic risk assessment and counselling.
The study hypothesis is that molecular screening will identify more patients with Lynch Syndrome than the family history alone.
Prospective data collection is performed using established clinical databases.
Looking for future studies?
Notify MeAll sexes
Observational
Department of Pathology, Esbjerg, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observation
Vejle Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01845753
Colonic Diseases, Colorectal Cancer
Aalborg, Denmark
View Trial DetailsNCT02198092
Adenoma, Adenomatous Polyposis Coli
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT01850654
Colonic Diseases, Colonic Neoplasms
Akron, Ohio, United States
View Trial DetailsNCT02645084
Colonic Diseases, Colorectal Cancer
View Trial Details